Moreover, after successful kidney transplantation in patients with chronic renal failure significant reduction of adiponectin serum concentration was found, implying that the kidney plays an important role in biodegradation and/or elimination from the circulation of adiponectin [139][140] and making this protein a biomarker of renal disease outcomes [139]. This evidence concerns the gene ADIPOQ and kidney disorder.